Strategic Capital and Infrastructure Solutions
LifeScienceX deploys structured capital through real assets to support regulated manufacturing environments critical to life sciences and health security.
We partner with operators to address capital, liquidity, and expansion requirements — aligning infrastructure with long-term production, delivery, and supply chain continuity.
Structured Real Asset Capital
LifeScienceX provides alternative capital solutions anchored in regulated real estate and mission-critical infrastructure.
We pursue:
- Strategic acquisition of manufacturing and production facilities
- Sale-leaseback transactions that unlock embedded real estate value
- Development partnerships for GMP, clinical, and scaled production environments
Our approach converts real estate into strategic growth capital while preserving operational continuity and long-term control.
Liquidity and Balance Sheet Optimization
Infrastructure aligned with life science and health security priorities often requires capital structures beyond conventional financing.
LifeScienceX partners with operators across diverse credit and liquidity profiles to:
- Monetize non-core or underutilized real estate
- Recapitalize owned facilities to fund R&D, scale-up, or commercialization
- Reposition infrastructure to meet evolving regulatory or operational demands
We structure capital solutions that enhance strategic flexibility while reinforcing long-term infrastructure durability.
Expansion and Capacity Solutions
We support operators at the intersection of life sciences and health security, including:
- CDMOs
- Cell and gene therapy manufacturers
- Pharmaceutical, biotech, and advanced therapy companies
- Academic medical centers and health systems
- Medical device and specialty manufacturing operators
New capacity requirements are addressed through acquisition or ground-up development strategies — ensuring facilities are aligned with GMP standards, operational scale, and long-duration performance.
Long-Term Infrastructure Stewardship
LifeScienceX is not a short-cycle capital provider.
We focus on infrastructure built to perform over decades — not cycles — supporting:
- Reliable manufacturing continuity
- Clinical production and precision medicine environments
- Durable pharmaceutical supply chains
- Long-term health security objectives
Our role extends beyond transaction execution to long-term asset stewardship and capital alignment.